Stable isotope-enriched selenite and selenate tracers for human metabolic studies: a fast and accurate method for their preparation from elemental selenium and their identification and quantification using hydride generation atomic absorption spectrometry.
Stable isotope tracers are safe and nutritionally relevant tools for the investigation of mineral metabolism in man. Increased research into the functional role of selenium has resulted in a need for well-characterised, isotopically enriched solutions of the element in order to determine the nutritional relevance of selenium fortification of foods. A simple method for the conversion of isotopically enriched elemental selenium (2.5-10 mg) into selenite and selenate, and their accurate characterisation and quantification is described. Analysis of selenite and selenate tracers using continuous-flow hydride generation-atomic absorption spectrometry technique was based on the specificity of the selenium hydride reaction and allowed their precise (RSD<2.5%) and accurate determination in aqueous solutions. The detection and determination limits were at 0.13 and 0.36 microg Se/l, respectively. Isotopically enriched elemental selenium was converted into selenite and selenate by a nitric acid and a combined nitric acid/hydrogen peroxide oxidation, respectively. The conversion was quantitative (>95%) and specific for both inorganic selenocompounds. Selenite and selenate labels were stable in 0.1 mol/l nitric acid for at least 18 months, i.e. making them ideally suitable for use in long-term metabolic studies. An overview of data relating to the absorption and retention of selenium by humans obtained using the two, well-characterised, tracers is presented and indicates that selenite and selenate are equally well retained in adult men and infants, despite differences in their absorption and urinary excretion characteristics.
Nestlé Research Centre (PVD, DB), P.O. Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne, Switzerland. peter.vandael@nestle.com
Peter
P
Van Dael
John
J
Lewis
Denis
D
Barclay
D006801:Humans; D007223:Infant; D008297:Male; D010084:Oxidation-Reduction; D011849:Radioactive Tracers; D064586:Selenic Acid; D018036:Selenium Compounds / Q000737:chemistry* / Q000378:metabolism; D012644:Selenium Radioisotopes / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D018038:Sodium Selenite / Q000737:chemistry* / Q000378:metabolism; D013054:Spectrophotometry, Atomic / Q000379:methods*
D011849:Radioactive Tracers; D018036:Selenium Compounds; D012644:Selenium Radioisotopes; D018038:Sodium Selenite; D064586:Selenic Acid